Process for preparing oligomeric peptide capable of inhibiting angiotonase activity
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- OCEAN UNIV OF CHINA
- Publication Date
- 2006-11-08
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a method for preparing oligopeptides capable of inhibiting angiotensinase activity by directional enzymatically hydrolyzing eggplant ginseng collagen with compound enzymes Background technique
[0002] Essential hypertension is caused by a variety of factors, including heredity, eating habits, and mental state. Studies have shown that whether blood pressure is normal or not is closely related to the renin-angiotensin system and the kallikrein-kinin system, and angiotensinase (ACE) plays an important role in the above two systems. In the renin-angiotensin system, ACE hydrolyzes non-pressor-active angiotensin I to produce pressor-active angiotensin II; while in the kallikrein-kinin system, ACE can degrade the The antihypertensive bradykinin loses its antihypertensive activity. ACE participates in the regulation of blood pressure in the body through the above two ways, which can cause the increase of blood pressure and cause hyp...